|
1
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research N, :
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Q, Chen X, Zhang M, Fan Q, Luo S and
Cao X: miR-137 is frequently downregulated in gastric cancer and is
a negative regulator of Cdc42. Dig Dis Sci. 56:2009–2016. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing
C and Liu Z: Altered expression of MiR-148a and MiR-152 in
gastrointestinal cancers and its clinical significance. J
Gastrointest Surg. 14:1170–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang X, Du L, Wang L, Li J, Liu Y, Zheng
G, Qu A, Zhang X, Pan H, Yang Y, et al: Serum microRNA expression
signatures identified from genome-wide microRNA profiling serve as
novel noninvasive biomarkers for diagnosis and recurrence of
bladder cancer. Int J Cancer. 136:854–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kohler CU, Bryk O, Meier S, Lang K,
Rozynek P, Brüning T and Käfferlein HU: Analyses in human
urothelial cells identify methylation of miR-152, miR-200b and
miR-10a genes as candidate bladder cancer biomarkers. Biochem
Biophys Res Commun. 438:48–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davalos V and Esteller M: MicroRNAs and
cancer epigenetics: A macrorevolution. Curr Opin Oncol. 22:35–45.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rouhi A, Mager DL, Humphries RK and
Kuchenbauer F: MiRNAs, epigenetics, and cancer. Mamm Genome.
19:517–525. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davis CD and Uthus EO: DNA methylation,
cancer susceptibility, and nutrient interactions. Exp Biol Med.
229:988–995. 2004. View Article : Google Scholar
|
|
13
|
Jones PA: DNA methylation errors and
cancer. Cancer Res. 56:2463–2467. 1996.PubMed/NCBI
|
|
14
|
Laird PW and Jaenisch R: DNA methylation
and cancer. Hum Mol Genet. 3:1487–1495. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Wylie RC, Andrews LG and Tollefsbol
TO: Aging, cancer and nutrition: The DNA methylation connection.
Mech Ageing Dev. 124:989–998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maruyama R, Toyooka S, Toyooka KO, Harada
K, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Vakar-Lopez F, Minna
JD, Sagalowsky A, et al: Aberrant promoter methylation profile of
bladder cancer and its relationship to clinicopathological
features. Cancer Res. 61:8659–8663. 2001.PubMed/NCBI
|
|
17
|
Fabbri M and Calin GA: Epigenetics and
miRNAs in human cancer. Adv Genet. 70:87–99. 2010.PubMed/NCBI
|
|
18
|
Kunej T, Godnic I, Ferdin J, Horvat S,
Dovc P and Calin GA: Epigenetic regulation of microRNAs in cancer:
An integrated review of literature. Mutat Res. 717:77–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: Playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balaguer F, Link A, Lozano JJ, Cuatrecasas
M, Nagasaka T, Boland CR and Goel A: Epigenetic silencing of
miR-137 is an early event in colorectal carcinogenesis. Cancer Res.
70:6609–6618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Varambally S, Cao Q, Mani RS, Shankar S,
Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al:
Genomic loss of microRNA-101 leads to overexpression of histone
methyltransferase EZH2 in cancer. Science. 322:1695–1699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi
D, Duan X, Xuan A, Zhang W, Lu J, et al: MicroRNA-152 targets DNA
methyltransferase 1 in NiS-transformed cells via a feedback
mechanism. Carcinogenesis. 34:446–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qi D, Li J, Que B, Su J, Li M, Zhang C,
Yang M, Zhou G and Ji W: Long non-coding RNA DBCCR1-003 regulate
the expression of DBCCR1 via DNMT1 in bladder cancer. Cancer Cell
Int. 16:812016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang J, Wang Y, Guo Y and Sun S:
Downregulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCq method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilson AS, Power BE and Molloy PL: DNA
hypomethylation and human diseases. Biochim Biophys Acta.
1775:138–162. 2007.PubMed/NCBI
|
|
28
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sutherland JE and Costa M: Epigenetics and
the environment. Ann NY Acad Sci. 983:151–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsuchiya N and Nakagama H: MicroRNA, SND1,
and alterations in translational regulation in colon
carcinogenesis. Mutat Res. 693:94–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Low SY, Ho YK, Too HP, Yap CT and Ng WH:
MicroRNA as potential modulators in chemoresistant high-grade
gliomas. J Clin Neurosci. 21:395–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nugent M: MicroRNA function and
dysregulation in bone tumors: The evidence to date. Cancer Manag
Res. 6:15–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stumpel DJ, Schotte D, Lange-Turenhout EA,
Schneider P, Seslija L, de Menezes RX, Marquez VE, Pieters R, den
Boer ML and Stam RW: Hypermethylation of specific microRNA genes in
MLL-rearranged infant acute lymphoblastic leukemia: Major matters
at a micro scale. Leukemia. 25:429–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miao CG, Qin D, Du CL, Ye H, Shi WJ, Xiong
YY, Zhang XL, Yu H, Dou JF, Ma ST, et al: DNMT1 activates the
canonical Wnt signaling in rheumatoid arthritis model rats via a
crucial functional crosstalk between miR-152 and the DNMT1, MeCP2.
Int Immunopharmacol. 28:344–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao
L, Cai H, Li P, Cao Q, Ju X, et al: miR-152 controls migration and
invasive potential by targeting TGFα in prostate cancer cell lines.
Prostate. 73:1082–1089. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng Z, Ma R, Tan W and Zhang L: MiR-152
suppresses the proliferation and invasion of NSCLC cells by
inhibiting FGF2. Exp Mol Med. 46:e1122014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma J, Yao Y, Wang P, Liu Y, Zhao L, Li Z,
Li Z and Xue Y: MiR-152 functions as a tumor suppressor in
glioblastoma stem cells by targeting Kruppel-like factor 4. Cancer
Lett. 355:85–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen S, Sanjana NE, Zheng K, Shalem O, Lee
K, Shi X, Scott DA, Song J, Pan JQ, Weissleder R, et al:
Genome-wide CRISPR screen in a mouse model of tumor growth and
metastasis. Cell. 160:1246–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y,
Qi YT, Xu Q, Li W, Lu B, et al: A regulatory circuit of
miR-148a/152 and DNMT1 in modulating cell transformation and tumor
angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 5:3–13.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nakagawa T, Kanai Y, Ushijima S, Kitamura
T, Kakizoe T and Hirohashi S: DNA hypermethylation on multiple CpG
islands associated with increased DNA methyltransferase DNMT1
protein expression during multistage urothelial carcinogenesis. J
Urol. 173:1767–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Szyf M and Detich N: Regulation of the DNA
methylation machinery and its role in cellular transformation. Prog
Nucleic Acid Res Mol Biol. 69:47–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: MiR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: A novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Miao CG, Yang YY, He X, Huang C, Huang Y,
Qin D, Du CL and Li J: MicroRNA-152 modulates the canonical Wnt
pathway activation by targeting DNA methyltransferase 1 in
arthritic rat model. Biochimie. 106:149–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wiklund ED, Kjems J and Clark SJ:
Epigenetic architecture and miRNA: Reciprocal regulators.
Epigenomics. 2:823–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sato F, Tsuchiya S, Meltzer SJ and Shimizu
K: MicroRNAs and epigenetics. FEBS J. 278:1598–1609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Azizi M, Teimoori-Toolabi L, Arzanani MK,
Azadmanesh K, Fard-Esfahani P and Zeinali S: MicroRNA-148b and
microRNA-152 reactivate tumor suppressor genes through suppression
of DNA methyltransferase-1 gene in pancreatic cancer cell lines.
Cancer Biol Ther. 15:419–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang J, Bian Y, Wang Z, Li D, Wang C, Li Q
and Gao X: MicroRNA-152 regulates DNA methyltransferase 1 and is
involved in the development and lactation of mammary glands in
dairy cows. PLoS One. 9:e1013582014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cui H, Wang L, Gong P, Zhao C, Zhang S,
Zhang K, Zhou R, Zhao Z and Fan H: Deregulation between miR-29b/c
and DNMT3A is associated with epigenetic silencing of the CDH1
gene, affecting cell migration and invasion in gastric cancer. PLoS
One. 10:e01239262015. View Article : Google Scholar : PubMed/NCBI
|
